Trial Profile
A Randomized, Open-label, Single Dose, Crossover, Phase Ⅰ Trial to Evaluate the Effect of Food on the Pharmacokinetics of LCB01-0371 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Delpazolid (Primary)
- Indications Bacterial infections; Gram-positive infections
- Focus Adverse reactions
- Sponsors LegoChem Biosciences
- 18 Mar 2017 Data from this trial was used in physiologically based pharmacokinetic modelling to predict the food effect on the PK of LCB01-0371 and compared to the observations from the clinical study; outcomes presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 22 Mar 2016 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
- 04 Sep 2015 New trial record